SEC Form 3 · accession 0001140361-26-027999
ROCKET PHARMACEUTICALS, INC. · RCKT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph Manhede
Officer — Principal Accounting Officer
Period of report
Jul 8, 2026
Accepted (ET)
Jul 8, 2026 · 7:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001281895
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 52,576 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents restricted stock units ("RSUs") that convert to common stock on a one-for-one basis that were granted to the Reporting Person on May 4, 2026. One-third (1/3) of such RSUs will become fully vested on May 4, 2027, with the remaining shares vesting in equal quarterly installments over the following two years.
Remarks
Exhibit 24: Power of Attorney